VR Laboratories Selects HSG1932 as Lead Development Candidate for Rhinovirus Program Company strengthens pipeline with potential therapy targeting virus responsible for common cold
LEE COUNTY, Fla., Nov. 29, 2012 /PRNewswire-iReach/ -- VR Laboratories LLC today announced they have selected a lead product candidate from their natural product library to target Rhinovirus. Rhinoviruses are the most common cause of acute upper respiratory tract infections (ARTI) or the common cold.
The common cold remains a tremendous burden to society with an enormous economic impact. There are an estimated 62 million colds per year in the United States that require therapeutic intervention. An estimated $227 million is spent on antibiotics and $2 billion on nonprescription cough and cold products in the US each year. In addition, 20 million days off work and 22 million days absent from school are attributable to ARTI each year.
HSG1932 is an orally administered and bioavailable product being developed for the relief of cold and flu-like symptoms.
"The common cold remains one of the most prevalent health problems in the world. We identified HSG1932 from our extensive library as our lead candidate to combat this problem based on its ability to inhibit rhinovirus infection in preclinical testing." said Jeff Kottkamp, CEO of VR Laboratories. "We are excited to be moving another leading edge product candidate forward in our growing pipeline of potential natural products targeting major human health problems with significant consumer and societal impact."
About VR Laboratories
VR Laboratories is an innovative natural products company formed by industry professionals in 2010 to be the leading global formulator and producer of natural products. VR Laboratories utilizes industry-changing proprietary technology to create, produce and market "First in Class" condition specific botanical based consumer health and wellness products, FDA-approved botanical pharmaceuticals and medicines, and proprietary ingredients for medicinal and functional foods and beverages. The company utilizes a proprietary technology platform created by HerbalScience, which has fully developed more than 1,000 medicinal and functional ingredients. VR Laboratories is headquartered in Lee County, Florida.
SOURCE VR Laboratories www.vr-laboratories.com
Keywords: VR Laboratories, cold, Jeff Kottkamp, natural, pharmaceuticals, botanical, RhinovirusMedia Contact:
Jeff Kottkamp, CEO VR Laboratories, LLC, 239-597-9878, Jeffkottkamp@vr-laboratories.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE VR Laboratories